Akzo Nobel N.V. (AMS:AKZA)
Netherlands · Delayed Price · Currency is EUR 48.98
-1.52 (-3.01%)
May 12, 2026, 5:36 PM CET
Akzo Nobel Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9,931 | 10,158 | 10,711 | 10,668 | 10,846 | 9,587 | |
Revenue Growth (YoY) | -7.05% | -5.16% | 0.40% | -1.64% | 13.13% | 12.39% |
Cost of Revenue | 5,952 | 6,109 | 6,374 | 6,434 | 6,923 | 5,683 |
Gross Profit | 3,979 | 4,049 | 4,337 | 4,234 | 3,923 | 3,904 |
Selling, General & Admin | 2,918 | 2,969 | 3,091 | 2,962 | 2,939 | 2,610 |
Research & Development | 274 | 274 | 296 | 270 | 258 | 230 |
Other Operating Expenses | -11 | -7 | 6 | -60 | - | -25 |
Operating Expenses | 3,181 | 3,236 | 3,393 | 3,172 | 3,197 | 2,815 |
Operating Income | 798 | 813 | 944 | 1,062 | 726 | 1,089 |
Interest Expense | -211 | -211 | -190 | -193 | -106 | -74 |
Interest & Investment Income | 50 | 49 | 61 | 69 | 36 | 15 |
Earnings From Equity Investments | 34 | 33 | 23 | 27 | 18 | 26 |
Currency Exchange Gain (Loss) | -49 | -49 | -47 | -128 | -65 | -21 |
Other Non Operating Income (Expenses) | -2 | 6 | 32 | -7 | 13 | - |
EBT Excluding Unusual Items | 620 | 641 | 823 | 830 | 622 | 1,035 |
Gain (Loss) on Sale of Assets | 655 | 655 | - | - | - | - |
Legal Settlements | -272 | -272 | - | - | - | 70 |
Other Unusual Items | -26 | -26 | 15 | -46 | -20 | - |
Pretax Income | 977 | 998 | 838 | 784 | 602 | 1,105 |
Income Tax Expense | 325 | 326 | 246 | 296 | 214 | 246 |
Earnings From Continuing Operations | 652 | 672 | 592 | 488 | 388 | 859 |
Earnings From Discontinued Operations | -1 | -1 | - | -5 | -10 | 6 |
Net Income to Company | 651 | 671 | 592 | 483 | 378 | 865 |
Minority Interest in Earnings | -30 | -36 | -50 | -41 | -26 | -36 |
Net Income | 621 | 635 | 542 | 442 | 352 | 829 |
Net Income to Common | 621 | 635 | 542 | 442 | 352 | 829 |
Net Income Growth | 32.69% | 17.16% | 22.62% | 25.57% | -57.54% | 31.59% |
Shares Outstanding (Basic) | 171 | 171 | 171 | 171 | 175 | 185 |
Shares Outstanding (Diluted) | 172 | 172 | 172 | 171 | 175 | 186 |
Shares Change (YoY) | -0.08% | 0.23% | 0.16% | -2.27% | -5.58% | -3.35% |
EPS (Basic) | 3.63 | 3.71 | 3.17 | 2.59 | 2.01 | 4.48 |
EPS (Diluted) | 3.61 | 3.69 | 3.16 | 2.58 | 2.00 | 4.46 |
EPS Growth | 32.82% | 16.91% | 22.44% | 28.85% | -55.11% | 35.90% |
Free Cash Flow | 645 | 605 | 362 | 834 | -38 | 316 |
Free Cash Flow Per Share | 3.75 | 3.52 | 2.11 | 4.87 | -0.22 | 1.70 |
Dividend Per Share | 1.980 | 1.980 | 1.980 | 1.980 | 1.980 | 1.980 |
Dividend Growth | - | - | - | - | - | 1.54% |
Gross Margin | 40.07% | 39.86% | 40.49% | 39.69% | 36.17% | 40.72% |
Operating Margin | 8.04% | 8.00% | 8.81% | 9.96% | 6.69% | 11.36% |
Profit Margin | 6.25% | 6.25% | 5.06% | 4.14% | 3.25% | 8.65% |
Free Cash Flow Margin | 6.49% | 5.96% | 3.38% | 7.82% | -0.35% | 3.30% |
EBITDA | 1,072 | 1,088 | 1,215 | 1,320 | 996 | 1,346 |
EBITDA Margin | 10.79% | 10.71% | 11.34% | 12.37% | 9.18% | 14.04% |
D&A For EBITDA | 274 | 275 | 271 | 258 | 270 | 257 |
EBIT | 798 | 813 | 944 | 1,062 | 726 | 1,089 |
EBIT Margin | 8.04% | 8.00% | 8.81% | 9.96% | 6.69% | 11.36% |
Effective Tax Rate | 33.27% | 32.66% | 29.36% | 37.76% | 35.55% | 22.26% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.